Elke, Gunnar http://orcid.org/0000-0002-4948-1605
,
Bloos, Frank
Wilson, Darius Cameron
Brunkhorst, Frank Martin
Briegel, Josef
Reinhart, Konrad
Loeffler, Markus
Kluge, Stefan
Nierhaus, Axel
Jaschinski, Ulrich
Moerer, Onnen
Weyland, Andreas
Meybohm, Patrick
Article History
Received: 15 October 2017
Accepted: 19 February 2018
First Online: 21 March 2018
Ethics approval and consent to participate
: The study protocol of the SISPCT trial was approved by the ethics board of Jena University Hospital (Internal File No. 2242-03/08). Written informed consent was obtained from all patients or their legal representatives.
: No individual participant data are reported that would require consent from the participant (or legal parent or guardian for children) to publish.
: All authors have provided information on potential conflicts of interests directly or indirectly related to the work submitted in the journal’s disclosure forms. FB reported receiving lecture honoraria from biosyn, Gilead, and CSL Behring and public funding for the SISPCT trial to his department by the German Federal Ministry of Education and Research, and unrestricted research grants for the SISPCT trial from biosyn and Thermo Fisher Scientific. DCW is an employee of BRAHMS GmbH. KR reported receiving personal fees from Adrenomed and being a shareholder of InflaRx Jena. SK reported receiving lecture fees from Astellas, Basilea, biotest, CSL Behring, CytoSorbents, Fresenius, Gilead, MSD, Pfizer and Thermo Fisher Scientific and being a member of advisory boards for Astellas, Fresenius, Gilead, MSD, Novartis and Pfizer. AN reported receiving lecture honoraria from Thermo Fisher Scientific. All other authors declared that they have no conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.